Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Non-cash Items (2016 - 2025)

Historic Non-cash Items for Viking Therapeutics (VKTX) over the last 11 years, with Q4 2025 value amounting to $2.9 million.

  • Viking Therapeutics' Non-cash Items fell 9797.35% to $2.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.9 million, marking a year-over-year decrease of 9797.35%. This contributed to the annual value of $2.9 million for FY2025, which is 9797.35% down from last year.
  • Viking Therapeutics' Non-cash Items amounted to $2.9 million in Q4 2025, which was down 9797.35% from $2.9 million recorded in Q3 2025.
  • Over the past 5 years, Viking Therapeutics' Non-cash Items peaked at $49.6 billion during Q2 2023, and registered a low of $1.1 million during Q3 2022.
  • In the last 5 years, Viking Therapeutics' Non-cash Items had a median value of $2.9 million in 2025 and averaged $3.8 billion.
  • Its Non-cash Items has fluctuated over the past 5 years, first surged by 388041643.19% in 2023, then crashed by 9999.15% in 2024.
  • Viking Therapeutics' Non-cash Items (Quarter) stood at $2.9 billion in 2021, then plummeted by 99.29% to $20.5 million in 2022, then surged by 203.24% to $62.2 million in 2023, then skyrocketed by 127.13% to $141.3 million in 2024, then plummeted by 97.97% to $2.9 million in 2025.
  • Its Non-cash Items stands at $2.9 million for Q4 2025, versus $2.9 million for Q3 2025 and $2.9 million for Q2 2025.